HEALTH.2013.2.3.4-2
HEALTH.2013.2.3.4-2
4 projects · €23,901,393 total EU contribution (project-level) · 50 participating organizations · 17 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€23,901,393
Countries active
Participant organizations by country (headquarters in CORDIS).
- France (9)
- Germany (8)
- UK (6)
- BR (5)
- Italy (4)
- Spain (3)
- AU (2)
- BE (2)
- Netherlands (2)
- SE (2)
- CH (1)
- EG (1)
- EL (1)
- IN (1)
- PT (1)
- SD (1)
- US (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- FIOCRUZ3 projects · BR
- ESP2 projects · DE
- Fraunhofer2 projects · DE
- INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR-IBMC2 projects · PT
- ADLEGO BIOMEDICAL AB1 projects · SE
- CSIC1 projects · ES
- ALU-FR1 projects · DE
- BNI1 projects · DE
- CERBM-GIE1 projects · FR
- CNRS1 projects · FR
- CNPEM1 projects · BR
- CEA1 projects · FR
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Kinetoplastid Drug Development: strengthening the preclinical pipeline KINDRED · 602773 | FP7 | €5,999,991 | €7,915,470 | Details |
Anti-Parasitic Drug Discovery in Epigenetics A-PARADDISE · 602080 | FP7 | €5,999,991 | €8,638,614 | Details |
New Medicines for Trypanosomatidic Infections NMTRYPI · 603240 | FP7 | €5,901,411 | €7,639,176 | Details |
Parasite-specific cyclic nucleotide phosphodiesterase inhibitors to target Neglected Parasitic Diseases PDE4NPD · 602666 | FP7 | €6,000,000 | €7,799,247 | Details |